CVE-2026-15415

Published: Jul 17, 2026Modified: Jul 20, 2026

6.8

Vector

CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:N/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:N/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:XShow less

Source: ff89ba41-3aa1-4d27-914a-91399e9639e5 (Secondary)

Description

AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research. Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input. To remediate this issue, users should upgrade to version 0.0.36 or later.

Related CWEs

CWE-23

Relative Path Traversal

The product uses external input to construct a pathname that should be within a restricted directory, but it does not properly neutralize sequences such as ".." that can resolve to a location that is outside of that directory.

References (3)

https://aws.amazon.com/security/security-bulletins/2026-060-aws/

Source: ff89ba41-3aa1-4d27-914a-91399e9639e5

https://github.com/awslabs/mcp/security/advisories/GHSA-6x7f-488g-75wm

Source: ff89ba41-3aa1-4d27-914a-91399e9639e5

https://pypi.org/project/awslabs.aws-healthomics-mcp-server/0.0.36/

Source: ff89ba41-3aa1-4d27-914a-91399e9639e5

Timeline

No history available yet.